170 related articles for article (PubMed ID: 3994700)
21. FAD-dependent regulation of transcription, translation, post-translational processing, and post-processing stability of various mitochondrial acyl-CoA dehydrogenases and of electron transfer flavoprotein and the site of holoenzyme formation.
Nagao M; Tanaka K
J Biol Chem; 1992 Sep; 267(25):17925-32. PubMed ID: 1517228
[TBL] [Abstract][Full Text] [Related]
22. Immunoprecipitation and electrophoretic analysis of four human acyl-CoA dehydrogenases and electron transfer flavoprotein using antibodies raised against the corresponding rat enzymes.
Ikeda Y; Tanaka K
Biochem Med Metab Biol; 1987 Jun; 37(3):329-34. PubMed ID: 3606893
[TBL] [Abstract][Full Text] [Related]
23. Genetic defects of acyl-CoA dehydrogenases: studies using an electron transfer flavoprotein reduction assay.
Hale DE; Stanley CA; Coates PM
Prog Clin Biol Res; 1990; 321():333-48. PubMed ID: 2326298
[No Abstract] [Full Text] [Related]
24. Defects of fatty-acid oxidation in muscle.
Angelini C
Baillieres Clin Endocrinol Metab; 1990 Sep; 4(3):561-82. PubMed ID: 2268228
[TBL] [Abstract][Full Text] [Related]
25. Reaction of electron-transfer flavoprotein with electron-transfer flavoprotein-ubiquinone oxidoreductase.
Beckmann JD; Frerman FE
Biochemistry; 1985 Jul; 24(15):3922-5. PubMed ID: 2996585
[TBL] [Abstract][Full Text] [Related]
26. Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool.
Zhang J; Frerman FE; Kim JJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16212-7. PubMed ID: 17050691
[TBL] [Abstract][Full Text] [Related]
27. Newly identified forms of electron transfer flavoprotein deficiency in two patients with glutaric aciduria type II.
Yamaguchi S; Orii T; Suzuki Y; Maeda K; Oshima M; Hashimoto T
Pediatr Res; 1991 Jan; 29(1):60-3. PubMed ID: 2000260
[TBL] [Abstract][Full Text] [Related]
28. [Glutaric acidemia type II].
Tanaka K; Ikeda Y; Finocchiaro G; Ito M
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):568-74. PubMed ID: 3270865
[No Abstract] [Full Text] [Related]
29. Human cDNA encoding ETF dehydrogenase (ETF:ubiquinone oxido-reductase), and mutations in glutaric acidemia type II.
Goodman SI; Bemelen KF; Frerman FE
Prog Clin Biol Res; 1992; 375():567-72. PubMed ID: 1438400
[No Abstract] [Full Text] [Related]
30. Multiple acyl-coenzyme A dehydrogenase deficiency: diagnosis by acyl-carnitine analysis of a 12-year-old newborn screening card.
Poplawski NK; Ranieri E; Harrison JR; Fletcher JM
J Pediatr; 1999 Jun; 134(6):764-6. PubMed ID: 10356148
[TBL] [Abstract][Full Text] [Related]
31. Glutaric aciduria type II: in vitro studies on substrate oxidation, acyl-CoA dehydrogenases, and electron-transferring flavoprotein in cultured skin fibroblasts.
Rhead W; Mantagos S; Tanaka K
Pediatr Res; 1980 Dec; 14(12):1339-42. PubMed ID: 7208150
[TBL] [Abstract][Full Text] [Related]
32. Electron transfer flavoprotein and electron transfer flavoprotein-ubiquinone oxidoreductase.
Frerman FE
Prog Clin Biol Res; 1990; 321():69-77. PubMed ID: 2183243
[No Abstract] [Full Text] [Related]
33. Expression of human electron transfer flavoprotein-ubiquinone oxidoreductase from a baculovirus vector: kinetic and spectral characterization of the human protein.
Simkovic M; Degala GD; Eaton SS; Frerman FE
Biochem J; 2002 Jun; 364(Pt 3):659-67. PubMed ID: 12049629
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a mutation that abolishes quinone reduction by electron transfer flavoprotein-ubiquinone oxidoreductase.
Beard SE; Goodman SI; Bemelen K; Frerman FE
Hum Mol Genet; 1995 Feb; 4(2):157-61. PubMed ID: 7757062
[TBL] [Abstract][Full Text] [Related]
35. Electron transfer flavoprotein deficiency: functional and molecular aspects.
Schiff M; Froissart R; Olsen RK; Acquaviva C; Vianey-Saban C
Mol Genet Metab; 2006 Jun; 88(2):153-8. PubMed ID: 16510302
[TBL] [Abstract][Full Text] [Related]
36. Prenatal diagnosis of glutaric acidemias.
Goodman SI
Prenat Diagn; 2001 Dec; 21(13):1167-8. PubMed ID: 11787045
[No Abstract] [Full Text] [Related]
37. Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency.
Cornelius N; Frerman FE; Corydon TJ; Palmfeldt J; Bross P; Gregersen N; Olsen RK
Hum Mol Genet; 2012 Aug; 21(15):3435-48. PubMed ID: 22611163
[TBL] [Abstract][Full Text] [Related]
38. A polymorphic variant in the human electron transfer flavoprotein alpha-chain (alpha-T171) displays decreased thermal stability and is overrepresented in very-long-chain acyl-CoA dehydrogenase-deficient patients with mild childhood presentation.
Bross P; Pedersen P; Winter V; Nyholm M; Johansen BN; Olsen RK; Corydon MJ; Andresen BS; Eiberg H; Kolvraa S; Gregersen N
Mol Genet Metab; 1999 Jun; 67(2):138-47. PubMed ID: 10356313
[TBL] [Abstract][Full Text] [Related]
39. Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation.
Chokchaiwong S; Kuo YT; Lin SH; Hsu YC; Hsu SP; Liu YT; Chou AJ; Kao SH
Free Radic Res; 2018 Dec; 52(11-12):1445-1455. PubMed ID: 30003820
[TBL] [Abstract][Full Text] [Related]
40. Catalytic defect of medium-chain acyl-coenzyme A dehydrogenase deficiency. Lack of both cofactor responsiveness and biochemical heterogeneity in eight patients.
Amendt BA; Rhead WJ
J Clin Invest; 1985 Sep; 76(3):963-9. PubMed ID: 3840178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
